MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The patient’s perspective: The effect of dopamine on Parkinson symptoms

    H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

    Objective: To investigate the correlation between patient-based vs. clinician-based L-Dopa effects on PD symptoms in tremor-dominant patients. Background: Medication adjustments are often solely based on…
  • 2016 International Congress

    Assessment of brainstem function with blink reflex variations in Parkinson’s disease

    D. Weise, C. Pargac, J.J. Rumpf, C. Fricke, J. Classen (Leipzig, Germany)

    Objective: To assess the brainstem function with different variations of blink reflex studies in Parkinson's disease (PD). Background: Although PD presents principally as a movement…
  • 2016 International Congress

    FYN expression is associated with regulatory region genetic variation

    L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

    Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation…
  • 2016 International Congress

    Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

    R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…
  • 2016 International Congress

    Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease

    J.J. Lee, Y. Lee, S.J. Chung, Y.H. Sohn, P.H. Lee (Seoul, Korea)

    Objective: To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD)…
  • 2016 International Congress

    A proposed Parkinson’s disease neuropsychological battery (PNB)

    L.L. van Wanrooij, J. Hoogland, J.G. Goldman, G. Stebbins, G.J. Geurtsen, D. Weintraub (Amsterdam, Netherlands)

    Objective: To propose a neuropsychological battery for assessing cognitive abilities in Parkinson's disease (PD) that also fulfills proposed MDS diagnostic criteria for PD mild cognitive…
  • 2016 International Congress

    Perception of time in music in Parkinson´s disease – Processing of musical syntax compensates rhythmic deficits

    D. Bellinger, E. Altenmüller, J. Volkmann (Wuerzburg, Germany)

    Objective: We investigated the time perception of Parkinson´s disease (PD) patients under the condition of music perception by detecting their individual temporal discrimination ability and…
  • 2016 International Congress

    Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET

    D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…
  • 2016 International Congress

    How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

    A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

    Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters)…
  • 2016 International Congress

    Bradykinesia, low monthly income and current employment are associated with depression in patients with Parkinson’s disease: Results of a study from Sri Lanka

    M.R. Withana, T.B. Herath, C. Rodrigo, C. Gamage, R. Gamage (Colombo, Sri Lanka)

    Objective: The objectives of this cross sectinal studies was to a) estimate the prevalence of depression and b) identify the associations for depression in a…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Welcome to the MDS Abstracts Site
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley